Your browser doesn't support javascript.
loading
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.
Uy, G L; Rettig, M P; Stone, R M; Konopleva, M Y; Andreeff, M; McFarland, K; Shannon, W; Fletcher, T R; Reineck, T; Eades, W; Stockerl-Goldstein, K; Abboud, C N; Jacoby, M A; Westervelt, P; DiPersio, J F.
Afiliação
  • Uy GL; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Rettig MP; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Konopleva MY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McFarland K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Shannon W; Division of General Medical Sciences, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Fletcher TR; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Reineck T; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Eades W; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Stockerl-Goldstein K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Abboud CN; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Jacoby MA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Westervelt P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Blood Cancer J ; 7(3): e542, 2017 03 10.
Article em En | MEDLINE | ID: mdl-28282031
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Fator Estimulador de Colônias de Granulócitos / Mobilização de Células-Tronco Hematopoéticas / Transplante de Células-Tronco / Compostos Heterocíclicos Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Fator Estimulador de Colônias de Granulócitos / Mobilização de Células-Tronco Hematopoéticas / Transplante de Células-Tronco / Compostos Heterocíclicos Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article